Acadian Asset Management LLC Kal Vista Pharmaceuticals, Inc. Transaction History

Acadian Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 07, 2023	SELL	$7.73 - $10.57 $1.21 Million - $1.65 Million	-155,935 Reduced 94.69%	8,736 $78,000
Q1 2023 May 11, 2023	SELL	$6.3 - $8.39 $2.17 Million - $2.88 Million	-343,816 Reduced 67.62%	164,671 $1.29 Million
Q4 2022 Feb 14, 2023	BUY	$4.2 - $14.24 $2.11 Million - $7.17 Million	503,446 Added 9987.03%	508,487 $3.44 Million
Q3 2022 Nov 14, 2022	BUY	$9.85 - $16.83 $49,653 - $84,840	5,041 New	5,041 $73,000
Q3 2021 Nov 12, 2021	SELL	$17.11 - $24.49 $102,694 - $146,988	-6,002 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$23.12 - $29.91 $138,766 - $179,519	6,002 New	6,002 $144,000

125

47.8M

551K

110K

Ticker KALV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,602,000
Market Cap $220M
Description
KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company, discovers, develops, and commercializes small molecule protease inhibitors for diseases with unmet needs. The company's product portfolio comprises small molecule plasma kallikrein inhibitors targeting hereditary angioedema (HAE) and diabetic macular edema (DME); and oral p...

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Acadian Asset Management LLC with notifications on news.